ABSTRACT. We measured plasma estradiol levels and ovarian volumes in eight girls with precocious puberty due to McCune-Albright syndrome. Six girls had gonadotropinindependent ovarian estrogen secretion and two girls had pubertal gonadotropin levels. Mean ovarian volume in all patients was significantly greater than in normal prepubertal girls. Mean ovarian volumes of the girls with McCuneAlbright syndrome overlapped the range found in girls with idiopathic central precocious puberty or central precocious puberty associated with central nervous system lesions. However, the degree of asymmetry between the right and left ovaries was significantly greater in girls with McCuneAlbright syndrome. Asymmetry was due, for the most part, to the presence of large solitary cysts in the larger of the two ovaries. In the six girls with McCune-Albright syndrome and gonadotropin-independent precocious puberty, both mean ovarian volume and the degree of asymmetry between the right and left ovaries were significantly correlated with plasma estradiol. Serum follicle-stimulating hormone bioactivity was increased in two patients but did not vary with ovarian cyst size. Thyroid-stimulating hormone levels were normal but serum prolactin was slightly elevated in one of the six girls with gonadotropin-independent precocious puberty. Fluctuation in the size of unilateral ovarian cysts appears to result in changes in the plasma estradiol level, leading to advancement and spontaneous regression of secondary sexual characteristics and menses in girls with McCune-Albright syndrome. The cause of the cyst formation is unknown but may be related to periodic elevation of as yet undefined serum factors such as follicle-stimulating hormone bioactive substances. (Pediatr Res 20: [859][860][861][862][863] 1986) Abbreviations FSH, follicle-stimulating hormone TSH, thyroid-stimulating hormone LH, luteinizing hormone LHRH, luteinizing hormone-releasing hormone CNS, central nervous system hCG, human chorionic gonadotropin
Girls with McCune-Albright syndrome have fibrous dysplasia of bone associated with cafE-au-lait skin pigmentation and/or precocious puberty (1, 2) . Advancement and regression of secondary sexual characteristics and episodes of menses in these girls often follow a cyclical course (3, 4) and in most girls, are independent of pubertal secretion of gonadotropins (3) (4) (5) (6) . In fact, gonadotropin levels are frequently suppressed below prepubertal levels (5) .
Regression of secondary sexual characteristics in girls with McCune-Albright syndrome has been observed when ovarian cysts or wedge sections of ovaries have been removed (7, 8) . Comite et al. (4) observed that in one girl with McCune-Albright syndrome, fluctuation of the size of a left ovarian cyst was associated with increases and decreases of plasma estradiol levels. In order to explore this association further, we compared ovarian volume and estradiol levels in eight girls who had precocious puberty associated with McCune-Albright syndrome. We have attempted to determine the etiology of cyst formation by examining serum FSH bioactivity and TSH and prolactin concentrations.
METHODS

Subjects.
The initial clinical and laboratory findings of the eight girls with McCune-Albright syndrome are indicated in Table 1 . All girls had fibrous dysplasia of bone and precocious puberty. Patients 1, 2, 4, and 6 had cafk-au-lait skin pigment: -tion. Patients I and 6 had extensive lower limb deformities with subsequent height loss. Patients 1 through 6 had prepubertal or suppressed gonadotropin levels whereas patients 7 and 8 had pubertal nocturnal LH pulsations and a pubertal gonadotropin response to injection of LHRH. Neoplasms were not detected by computed tomography of the head or by ultrasonography of the pelvis and adrenal glands. Plasma 17-hydroxyprogesterone and 1 1-deoxycortisol, measured to exclude congenital adrenal hyperplasia, were normal. Serum T4 levels were also normal.
Girls with central precocious puberty, either idiopathic (n = 33) or associated with a CNS lesion (n = 8), ranged from 1 to 18 yr of age. All had stage I1 or greater pubertal development [according to the method of Tanner (9) ], advanced bone age for chronological age, and accelerated height velocity. All had a pubertal response of gonadotropins in response to LHRH and/ or nocturnal pulsations of LH. Girls were included for study only after exclusion of ovarian or adrenal neoplasms by ultrasonography, and all had normal serum 17-hydroxyprogesterone and 1 1 -deoxycortisol. Protocol. 8 has been shown previously (3) .
t According to the method of Tanner (9) .
Health and Human Development. Informed consent was obtained from a parent and assent was obtained from children more than 7 yr of age.
LHRH stimulation was performed by administration of 100 pg of LHRH intravenous at time 0 and gonadotropin levels were determined at -30, -15, 0, 15, 30, 45, 60, 90, and 120 min. Estradiol was determined as the mean of four values obtained at 1000, 1400, 2200, and 0200 h. Children with McCune-Albright syndrome were either followed without treatment or treated with the long-acting agonist of LHRH, D-Trp6-Pro9-NEt-LHRH (LHRH,) at a dose of 4 pg/kg/day subcutaneous. This analog has been shown to supress gonadotropins thereby suppressing estradiol levels in girls with central precocious puberty (10, 1 I), but has not influenced estradiol levels in girls with gonadotropinindependent ovarian estrogen secretion (4, 5) . Serial ultrasounds and estradiol measurements (mean of four values as above) were obtained in patients 1, 2, 3, and 5 at approximately 3-month intervals.
Hormone assays. Serum LH, FSH, and estradiol were measured by modifications of previously described methods (Second International Reference Preparation of Human Menopausal gonadotropin) (1 2-14) . Sensitivity of the estradiol assay was 20 pg/ ml, and intra-and interassay coefficients of variation were 8 and 16%, respectively. TSH and prolactin were measured by radioimmunoassay as previously described (15, 16) .
FSH bioassay. FSH bioactivity was quantified by means of FSH-dependent aromatase activity (conversion of androgen substrate to estradiol). Following decapitation, testes from 7-to 10-day-old Sprague Dawley rats were decapsulated and incubated in a combination of Dulbecco's and Ham's F10 (1:I) medium containing 0.03% collagenase and 0.003% soybean trypsin inhibitor for 5-10 min at 34" C. Medium was decanted to remove interstitial cells. The tubules were washed and resuspended in medium containing 0.03% collagenase, 0.003% soy trypin inhibitor, and 0.03% DNase for 30 min at 34" C. Dispersion of Sertoli cells was hastened by mechanical dispersion with a pasteur pipette. The resulting cell suspension was washed three times, and cells resuspended in medium [formulation based on Rich et al. (1 7)] containing 19-OH androstenedione (2.5 pM) and methyl isobutyl xanthine (0.1 mM). One ml of cell suspension was transferred to each well of a multiwell culture dish (Falcon, diameter 16 mm). The cells were washed and reincubated in incubation medium containing increasing concentrations NIAMDD hFSH 1-2 (AFP 2844B, biopotency 3925 IU/mg; immunopotency 5226 IU/mg) or with unknown serum samples (3 and 5 pl). Following a 24-h incubation, medium was aspirated and assayed for estradiol by radioimmunoassay (1 8) . The sensitivity of the bioassay system was 0.01 ng/ml and index of precision 0.049. The assay is specific for FSH bioactivity (19) (Padmanabhan V, unpublished data).
Ultrasonography. Pelvic ultrasonography, using a static Bscanner, duplicated that described by Sample et al. (20) . Ovarian volumes were calculated by the 3-dimensional diameters from sagittal and transverse scanning and then using the formula: volume = 0.5 (width X thickness x length).
Statistical analysis. Data are represented as the mean k SEM. Statistical comparisons were made by Student's t test. Correlations of estradiol and ovarian volume were determined by least squares linear regression analysis.
RESULTS
Ovarian volumes in McCune-Albright syndrome and in central precociouspuberty. Mean volumes in girls with
McCune-Albright syndrome overlapped the range seen in girls with idiopathic or CNS lesion associated central precocious puberty (Fig. IA) . However, when individual ovarian volumes were compared, girls with McCune-Albright syndrome had greater asymmetry of ovarian volume than did the girls with central precocious puberty (Fig. 1B) . The difference in right to left ovarian volume was significantly greater in girls with McCune-Albright syndrome (p < 0.05, difference of 5.5 f 1.5 ml) as compared to those with central precocious puberty (1.5 f 0.2 ml). In patients 2, 3, and 4, a cyst of greater than 1 cm in diameter was present in the larger ovary. In patients 2 through 6, large cysts were documented at various times, unilaterally, during longitudinal study. The cysts always occurred in the same ovary in patients 3, 4, and 5. Cysts were documented in both ovaries of patient 2 although asymmetry persisted and the right ovary was always larger than the left when estradiol was elevated. In patient 6, the left ovary had been previously excised because of the presence of a large ovarian cyst. Subsequently, the right ovary developed a large cyst. In patient 8, multiple small cysts were noted in both ovaries. Cysts were not seen in ultrasounds of patients 1 and 7.
Estradiol levels and ovarian volume. The girls with McCuneAlbright syndrome initially presented with estradiol levels ranging from less than 20 to 133 pg/ml although all had evidence of advanced secondary sexual characteristics and advancement of bone age. This indicated that estradiol levels must have been elevated in all these girls and may have fluctuated over time. We compared the ovarian volumes of the girls with undetectable estradiol levels at their initial visit (less than 20 pg/ml) to those with detectable estradiol levels (greater than 20 pg/ml). The girls with detectable levels had significantly larger (7.6 f 1.2 ml) ovarian volumes than did girls with undetectable estradiol levels (2.8 k 0.8 ml, p < 0.02). Patients 1, 2, 3, and 5, who had low gonadotropin levels, were followed longitudinally for 1 or more yr at 3-to 6-month intervals with pelvic ultrasound examinations and determination of estradiol levels. These girls had been treated for 3-12 months with LHRH, but had shown no decrease in serum gonadotropin levels nor in estradiol fluctuation (5) . Over time, mean ovarian volumes fluctuated and were increased in association with elevation of estradiol levels [r = 0.79, p < 0.001 ( Fig. 2A) Fig. 2 . Plasma estradiol levels and ovarian volume in girls with gonadotropin-independent precocious puberty. Data from patients 1, 2, 3, and 5, in whom sequential ultrasounds were done, are represented. Patients were either untreated or treated with LHRH,. Estradiol is expressed as the mean of four samples obtained at 1000, 1400, 2200, and 0200. A, comparison of plasma estradiol with mean ovarian volume. but believed to be related to elevated TSH levels which may, in turn, increase gonadotropin or prolactin secretion. Also, the gonadotropins and TSH share a common a-subunit. This potentially might lead to hormonal overlap increasing gonadal activity which would result in precocious puberty. Pituitary hyperfunction has been reported in McCune-Albright syndrome especially for prolactin and growth hormone (22, 23) . Thus, we examined TSH and prolactin in the six patients with gonadotropin independent precocious puberty ( Table 2 ). The TSH levels were volume also correlated with increases in plasma estradiol level [r = 0.72, p < 0.001 (Fig. 2B) normal in all subjects tested. Prolactin was slightly increased in one subject at the time she had a large left ovary (13 ml) with a cyst. However, prolactin was normal in the remaining four subjects tested irregardless of ovarian size. None of the patients exhibited hyperthyroidism, as assessed by T, radioimmunoassay at the time of study. Serum FSH bioactivity. It is believed that complete ovarian function cannot occur without FSH priming, principally since girls with hCG-producing tumors have not been reported to develop precocious puberty. Our patients with McCune-Albright syndrome appeared to have functioning ovarian cysts but low to suppressed levels of FSH. It is possible that the serum of these girls might have a substance with FSH bioactivity that was not recognized in our FSH radioimmunoassay. FSH bioactivity was determined in serum from patients 1, 2, 3, and 5 during periods with small ovaries and periods with large ovarian cysts (Table 3) . In this bioassay, normal pubertal girls had serum FSH bioactivity of 32 k 4 ng/ml ( n = 6). Normal adult women in early follicular phase of the menstrual cycle had FSH bioactivity of 202 k 71 nglml (n = 6). We have not been able to detect FSH bioactivity in normal prepubertal subjects to date. In contrast, two girls with McCune-Albright syndrome (patients 1 and 5 ) had detectable FSH bioactivity despite low levels of FSH by radioimmunoassay. Patient 3 had FSH bioactivity in one sample that was at the borderline of detectability. Unilateral ovarian enlargement was evident by ultrasound at the time FSH bioactivity was increased in patients 1, 3, and 5. However, no clearly evident increase in FSH bioactivity was seen in patient 2 at times when large ovarian cysts were present in her ovaries.
Girls with McCune-Albright syndrome may have a number of endocrinological abnormalities in addition to sexual precocity. Those include hyperfunction of the thyroid (24), Cushing syndrome (25) , and pituitary abnormalities (22) . The cause of the endocrine hyperfunction is, as yet, unknown. Hall and Warrick (26) proposed the etiology was related to abnormal or excessive signals from the hypothalamus. However, the majority of patients with McCune-Albright syndrome and sexual precocity have very low levels of gonadotropins (3, 4, 6) and do not exhibit further suppression of gonadotropins nor cessation of menses when treated with long-acting agonists of LHRH. Thus, excess neurotransmitters or excess LHRH secretion cannot account for sexual precocity in most girls with McCune-Albright syndrome, and other etiologies must be investigated.
We have documented that all six girls in our study who had gonadotropin-independent precocious puberty also had enlarged ovaries. Five of the six had intermittent presence of large unilateral ovarian cysts. Ovarian growth with cyst formation appears to be responsible for increases in estradiol production in these girls. Surgical examination has shown that these cysts are generally follicular (2) . Despite the formation of such cysts, we and others have not demonstrated elevated progesterone levels in any patients indicating that ovulation has not occurred (2) (Foster CM, unpublished observations).
Ovarian cysts have been seen in association with precocious puberty. Notably, girls with severe hypothyroidism may develop large, multicystic ovaries (21) in response to hormonal overlap from TSH or prolactin (27) . TSH shares a common a-subunit with the gonadotropins. However, none of our patients had high TSH levels. Prolactin levels were normal in four of the five girls tested with gonadotropin-independent precocious puberty. This makes an overlap in hormonal sensitivity less likely in these patients.
Circulating factors with gonadotropin bioactivity but little gonadotropin immunoactivity theoretically could stimulate ovarian growth in our patients. Previously we determined LH bioactivity using the rat interstitial cell testosterone production assay in patients 1 and 3 to 6 (3). LH bioactivity was not detectable in any of the girls with low gonadotropin levels. This is in agreement with others who have determined LH bioactivity in girls with McCune-Albright syndrome (6) (Beitins IZ, unpublished observation). In contrast, FSH bioactivity was detected in at least two of our patients. FSH bioactivity did not correlate well with ovarian cyst presence nor with estradiol level. Thus, the significance of this observation is, as yet, unclear.
The fluctuation of ovarian cyst size with consequent fluctuation of plasma estradiol levels appears to be responsible for sexual precocity in girls with McCune-Albright syndrome. Each girl appears to have her own rhythm of cyst production. Cysts have appeared monthly or bimonthly in some of our patients whereas others had cyst formation and exacerbation of symptoms after prolonged quiescent periods of a year or more. We and others have observed that removal of the cyst results in only temporary improvement as remaining ovarian tissue may form cysts (8) . Hence surgical intervention is not usually beneficial. Experimental therapy based on interference with estradiol production by use of aromatase inhibitors such as A-1-testolactone has shown more promise (28) . The decrease in ovarian cyst size with testolactone therapy suggests that, possibly, there is an imbalance between estrogens and androgens which allows an ovarian cyst to grow. Improved understanding of the cause of ovarian growth in girls with McCune-Albright syndrome will be necessary to improve treatment and outcome.
